1. AB0025 Prevalence of MEFV gene mutations in apparently healthy populations in balkan and central european countries. (23rd January 2014) Authors: Debeljak, M.; Toplak, N.; Abazi, N.; Kolnik, M.; Szabados, B.; Mulaosmanovic, V.; Constantin, T.; Kuzmanovska, D.; Avcin, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0984 Development of a Juvenile Systemic Sclerosis Response Index (JSSRI). (9th June 2015) Authors: Foeldvari, I.; Györgyi, Z.; Baildam, E.; Batu, E.D.; Blakley, M.; Cakan, M.; Curran, M.; Fligelstone, K.; Mouthon, L.; Nemcova, D.; Pilkington, C.; Ruperto, N.; Tsinti, M.; Tsitsami, E.; Urbanvica, K.; Constantin, T. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB1162 Looking for minimum standards in care for children with localized scleroderma-result of the consensus meeting in hamburg germany on the 11th of december 2011. Part I. diagnosis and assessment of the disease. (23rd January 2014) Authors: Foeldvari, I.; Constantin, T.; Höger, P.; Nemcova, D.; Pain, C.; Torok, K.; Weibel, L.; Clements, P. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB1163 Looking for minimum standards in care for children with localized scleroderma-result of the consensus meeting in hamburg germany on the 11th of december 2011. Part II. treatment of juvenile localised scleroderma. (23rd January 2014) Authors: Foeldvari, I.; Constantin, T.; Höger, P.; Nemcova, D.; Pain, C.; Torok, K.; Weibel, L.; Clements, P. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB1182 Efficacy and safety of canakinumab, fully human anti-interleukin-1beta antibody, in systemic juvenile idiopathic arthritis. (23rd January 2014) Authors: Ruperto, N.; Brunner, H.; Quartier, P.; Constantin, T.; Wulffraat, N.; Horneff, G.; Brik, R.; McCann, L.; Kasapcopur, O.; Rutkowska-Sak, L.; Schneider, R.; Berkun, Y.; Calvo, I.; Erguven, M.; Goffin, L.; Hofer, M.; Kallinich, T.; Knupp, S.; Uziel, Y.; Viola, S. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB1186 IL-1beta inhibition with canakinumab in patients with systemic juvenile idiopathic arthritis: Efficacy and safety outcomes from a single-dose, placebo-controlled study. (23rd January 2014) Authors: Quartier, P.; Erguven, M.; Horneff, G.; Berkun, Y.; Lheritier, K.; Kim, D.; Abrams, K.; Constantin, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0409 Do we need minimum standards in care for children with localized scleroderma?- result of the consensus meeting in hamburg germany on the 11th of december 2011. part ii. treatment of juvenile localised scleroderma. (23rd January 2014) Authors: Foeldvari, I.; Constantin, T.; Hoeger, P.; Moll, M.; Nemcova, D.; Pain, C.; Torok, K.; Weibel, L.; Clements, P. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0496 Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis with and Without Fever. (9th June 2015) Authors: Ruperto, N.; Brunner, H.; Quartier, P.; Constantin, T.; Alexeeva, E.; Kone-Paut, I.; Marzan, K.; Wulffraat, N.; Schneider, R.; Padeh, S.; Chasnyk, V.; Wouters, C.; Kummerle Deschner, J.; Kallinich, T.; Lauwerys, B.; Haddad, E.; Nasonov, E.; Trachana, M.; Vougiouka, O.; Abrams, K. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0062 The Addition of One or More Biologics to Methotrexate in Children with Juvenile Idiopathic Arthritis Increases the Incidence of Infections and Serious Adverse Events. The 5882 Pharmachild Cohort. (9th June 2015) Authors: Swart, J.; Pistorio, A.; Bovis, F.; Alekseeva, E.; Hofer, M.; Nielsen, S.; Anton, J.; Consolaro, A.; Panaviene, V.; Stanevicha, V.; Trachana, M.; Ailioaie, C.; Quartier, P.; De Benedetti, F.; Tsitsami, E.; Flato, B.; Dolezalova, P.; Constantin, T.; Herlin, T.; Kamphuis, S. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0136 Baseline Characteristics of Patients with Active Systemic JIA Successfully Discontinuing Corticosteroid while Receiving Canakinumab: Secondary Analysis from a Pivotal Phase 3 Trial. (23rd January 2014) Authors: Ruperto, N.; Brunner, H.; Constantin, T.; Wulffraat, N.; Horneff, G.; Anton, J.; Berner, R.; Corona, F.; Cuttica, R.; Desjonqueres, M.; Fischbach, M.; Alessio, M.; Chieng, A.; Emminger, W.; Haddad, E.; Lheritier, K.; Abrams, K.; Hruska, J.; Kim, D.; Martini, A. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗